professorInstitute of Basic Medical Sciences, Chinese Academy of Medical SciencesBeijing, Beijing, China (People's Republic)
OC 19.3 - PAR1 Inhibition Vorapaxar as a Potential Therapeutic Approach in Chronic Thromboembolic Pulmonary Hypertension: Experimental Insights and Implications
Sunday, June 23, 202410:00 – 10:15 ICT
OC 42.5 - Serum proteome profiling reveals Heparanase as a candidate biomarker for chronic thromboembolic pulmonary hypertension
Monday, June 24, 202415:45 – 16:00 ICT
PB1338 - The therapeutic potential of NAMPT in protecting against chronic thromboembolic pulmonary hypertension
Tuesday, June 25, 202413:45 – 14:45 ICT
